GI Pharmacology Flashcards
What is the product/function of Parietal Cells?
HCl for Protein Digestion, Sterilization, and Nutrient Absorption
What is the product/function of Superficial Epithelial/Neck Cells?
Mucus and Bicarbonate for gastroprotection
What is the product/function of ECL cells?
Histamine, which promotes HCl secretion
What is the product/function of G cells?
Gastrin, which promotes HCl secretion
What are the key regulatory of paracrine, endocrine, and neuronal acid seretion?
Paracrine –> Histamine
Endocrine –> Gastrin
Neuronal/Neurocrine –> Acetylcholine
What are the Direct/Indirect regulators of acid secretion from the parietal cells?
Gastrin and Acetylcholine
Directly stimulate the Parietal Cell
Indirectly stimulate the ECL Cells
What are the 3 key roles of prostaglandins?
- Mucus and Bicarbonate secretion
- Suppression of HCL secretion
- Increase gastric blood flow
What type of ulcer has the greatest frequency?
Duodenal Ulcers
Stress Ulcer (Definition)
Peptic ulcer caused by illness, systemic trauma, neuronal injury, emotions
Cushing Ulcer (Definition)
Stress ulcer associated with Head Trauma or Brain Surgery
Ischemic Ulcer (Definition)
Ulcer caused by hemorrhage, multi-system trauma, severe burns (Curling ulcer), heart failure, sepsis
What are the two most common causes of ulcers in the U.S.?
NSAIDs (COX inhibition) and H. pylori
Symptoms of an ulcer
1. Abdominal Pain (particularly after a meal)
- Nausea
- Vomiting, vomiting blood
- Bloody, tarry school
- Indigestion
- Weight loss
- Fatigue
Antacids (Therapeutic Goals)
Neutralize the acid in the stomach to a pH > 4
End products: Salt, Water (sometimes CO2)
No Target Receptor
Sodium Bicarbonate - NaHCO3 (Rate of Reactivity, Specific Adverse Effects)
Rate of Reactivity: FAST
Specific Adverse Effects: Metabolic acidosis, excessive NaCl absorption, Gas/Bloating (CO2__)
Calcium Carbonate - CaCO3 (Duration of Action, Rate of Reactivity, Specific Adverse Effects)
DoA: 1-2 hours
RoR: MODERATE
SAE: Acid Rebound (Feed forward mechanism causing INCREASED acid production after long-term use), Gas/Bloating (CO2), Hypercalcemia (large doses), Hypophosphatemia (Rare)
Magnesium Hydroxide - Mg(OH)2 (Rate of Reactivity, Specific Adverse Effects)
RoR: SLOW
Specific Adverse Effects: Osmotic Diarrhea (due to excess Salt in intestines), Hypermagnesemia (large doses over an extended period of time)
Aluminum Hydroxide - Al(OH)2 (Rate of Reactivity, Specific Adverse Effects)
RoR: SLOW
SAE: Constipation (slows down smooth muscle peristalsis), Aluminum toxicity (impaired RENAL FUNCTION), Hypophosphatemia, Bone Resorption, Hypercacelmia
Duration of Action of Antacids
Very SHORT (1-2 Hours)
***Have to take them very frequently, therefore, will see a Decrease in Compliance
Two common Adverse Effects of Anatacids
- Reduced Drug Bioavailability
- Enteric Infection
Therapeutic Uses of Antacids
GERD, Peptic Ulcers, Dyspepsia
Anatacids are used as adjunctive therapy with____
PPIs
Antacids are equally efficacious as _____ at treating GERD (heal rate = ___%) and Peptic Ulcers (heal rate = ___%)
Antacids are equally efficacious as H2-Receptor Antagonists at treating GERD (heal rate = 50%) and Peptic Ulcers (heal rate = 80%)
H2-receptor Antagonists
- Type of inhibition/Selectivity
- What is blocked?
- Competitive and Highly Selective
- Blocks Indirect action of Gastrin and Acetylcholine; Does not block direct action of Gastrin and Acetylcholine
What do all H2-receptor Antagonist names end in?
They all end in -tidine
H2-receptor Antagonists
Drug Names (4 of them)
- Cimetidine (Tagemet)
- Ranitidine (Zantac)
- Nizatidine (Axid)
- Famotidine (Pepcid)
H2-receptor Antagonists
- Duration of Action
- Common Adverse Effects
DoA: 10 hours or 6 hours OTC
CAE: Headache, diarrhea, fatigue, constipation, infection, drug kinetics, bradycardia (IV), hypotension (IV)
H2-receptor Antagonists
- Specific Considerations for Cimetidine
- CNS Effects (confusion, hallucinations, agitation)
- Endocrine Effects (inhibition of androgen receptors, inhibition of estradiol metabolism, increase prolactin levels)
- Inhibition of hepatic CYB metabolism (Inhibits cytochrome P450 activity, which leads to high potential of drug-drug interactions)
H2-receptor Antagonists
- Key Difference from Antacids
- Key Advantage compared to Antacids
- Must be absorbed into the BLOODSTREAM to take effect
- Have to be administered LESS often
(Equally efficacious as antacids at treating GERD and Peptic Ulcers and can additionally treat Gastritis)
Proton Pump Inhibitors (PPIs)
- Key Advantage over H2-receptor Antagonists
- Antagonizes the proton pump, so is able to block both Direct and Indirect actions of ACh, Histamine, and Gastrin
Proton Pump Inhibitors (PPIs)
- Mechanism of Action (5 things)
- Activated by low pH
- Acid-labile drug is absorbed into the BLOODSTREAM by GI
- Concentrates at the site of action (Parietal Cells)
- Irreversibly binds/inhibits proton pump
- Activation of pump requires new synthesis
What do all Proton Pump Inhibitors end in?
All PPIs end in -prazole
Proton Pump Inhibitors (PPIs)
- Drug Names
- Omeprazole (Prilosec)
- Lansoprazole (Prevacid)
- Rabeprazole (Aciphex)
- Esomeprazole (Nexium)
- Pantoprazole (Protonix)
Proton Pump Inhibitors (PPIs)
- Duration of Action
DoA: 24 hours (takes 3-4 days of dosing to reach max effect)
Proton Pump Inhibitors (PPIs)
- Common Adverse Effects
***Extremely SAFE***
- Decreased drug bioavailability
- Diarrhea, headache, abdominal pain (1-5%)
- Decreased nutrient absorption (Vitamin B12, Iron, Calcium, Zinc)
- Enteric and Respiratory infections
Why does it take 3-4 days for PPIs to reach maximum effect?
It takes 3-4 days for the body to exhaust its supply of proton pumps, which are waiting in the tubulovesicular network to be brought to the apical surface and inactivated by the PPI
***This is why you initially supplement w/ Antacids or H2-receptor Antagonists***
Proton Pump Inhibitors (PPIs)
- Therapeutic Uses
GERD
Peptic Ulcers
Dyspepsia
Gastritis
Hypersecretory Diseases
NSAID-associated Ulcers
H. pylori-associated Ulcers
Proton Pump Inhibitors (PPIs)
- Effectiveness
- Most Efficacious Inhibitors
(GERD Heal Rate = 90%)
(Peptic Ulcer Heal Rate = 90%)
Muscoal Protective Agents
- Drug Names
Sucralfate (Carafate)
Misoprostol (Cytotec)
Bismuth subsalicylate (Pepto-Bismol)
Mucosal Protective Agents
- Mechanism of Action
Sucralfate and Bismuth subsalicylate both create a physical barrier and stimulate mucus and HCO3- secretion from the gastric mucosa
Misoprostol (a prostaglandin derivative) stimulates mucus and HCO3- secretion from the gastric mucosa, but DOES NOT form a physical barrier
Mucosal Protective Agents
- Duration of Action
6 hours
Mucosal Protective Agents
- Common Adverse Effects - Sucralfate
- Other Adverse Effects
- Constipation, Impaired Drug Absorption
- Caution w/ Renal Insufficient Patients
***Constipation (inhibition of smooth muscle contraction) and Renal Toxicity due to presence of Aluminum***
Mucosal Protective Agents
- Common Adverse Effects - Misoprostol
- Other Adverse Effects
- Cramping, Diarrhea
- Abortificient (stimulates smooth muscle contractions, so could induce uterine contractions)
Mucosal Protective Agents
- Common Adverse Effects - Bismuth subsalicylate
- Other Adverse Effects
- Blackening of Stool and Tongue
- High doses - Salicylate Toxicity
Reasons to use Mucosal Protective Agents
- Generalyl 2nd line agents to PPIs
- Sucralfate –> prevents stress-related bleeding when you DO NOT want to prevent acid secretion (hospitalized patient who is at risk for infection)
- Misoprostol –> NSAID-associated ulcers
- Bismuth subsalicylate –> H. pylori-associated ulcers, Travelers diarrhea, Dyspepsia (indigestion)
H. pylori and Gastric Ulcers
- 70 to 90% of patients with ________ are infected with H. pylori
- Transmission of H. pylori
70 to 90% of patients with Gastric or Duodenal Ulcers are infected with H. pylori
- Orally via Fecal Matter (tainted water) or transmitted from stomach to mouth from GERD or belching
H. pylori and Gastric Ulcers
- Treatment of H. pylori (Triple Theory)
- Key of Treatment
- PPI –> Clarithromycin –> Amoxicillin
(Can used Metronidazole in place of Amoxicillin if there is a penicillin allergy)
- Two antibiotics given due to the high resistance of H.pylori ***Know***
MUST USE 3 drugs –> suppress acid secretion and two antibiotics
Old Triple Theory (Bismuth subsalicylate, Tetracycline, Metronidazole)
Quadruple Therapy –> New Triple Theory + Bismuth subsalicylte
Summary of Antacids, H2-receptor Antagonists, PPIs, and Mucosal Protective Agents
Serotonin (5-HT)
- Function in the GI System
- (Within the Enteric Nervous System) Stimulates gastric motility by inducing the release of Ach by neurons onto GI smooth muscle
Acetylcholine
- Function in the GI System
- Regulation
- Binds to Muscarinic (M3) receptors and induces conraction of the GI smooth muscle
- Concentrations regulated at neuromuscular junction by Acetylcholine esterase (AchE)
What is the function of Dopamine (D2) receptors in the GI system?
Pre-synaptic receptors involved in regulating the release of neurotransmitters:
Stimulate D2 receptor –> DECREASED** acetylcholine production –> **DECREASED motility/neuronal firing/smooth muscle contraction
What is the function of the Motilin Receptor (MR) in the GI system?
Motilin is a hormone that is released and promotes motility in the UPPER GI tract (stomach, duodenum)
***Has less effect as you move lower
Metoclopramide (Reglan)
- Mechanism of Action
- Used to Treat
- Adverse Effects
MoA: D2 Antagonist
***Promotes Motility***
Use: GERD, Impaired Gastric Emptying, Dyspepsia, Antiemetic
AE: CNS (restlessness, drowsiness, insomnia, anxiety), ***Altered Motor Function (Parkinsonian Symptoms)*** due to blocking of Dopamine
Bethanechol (Urecholine)
- Mechanism of Action
- Used to Treat
- Adverse Effects
MoA: M3 Agonist
***Promotes Motility***
Use: GERD, Gastroparesis
AE: Cholinergic side effects
Neostigmine (Prostigmin)
- Mechanism of Action
- Used to Treat
- Adverse Effects
MoA: AchE inhibitor
***Promotes Motility***
Use: Non-obstructive: urinary retation and abdominal distension
AE: Cholinergic side effects
Erythromycin (Erythrocin)
- Mechanism of Action
- Used to Treat
- Adverse Effects
MoA: Motilin Receptor Agonist
***Promotes Motility***
Use: Gastroparesis
AE: Erythromycin-mediated side effects (alterations of the normal gut flora)
Laxatives (Bulk-Forming)
e.g. Wheat Bran, Psyllium (Konsyl-D, Metamucil), Methycellulose (Citrucel), Polycarbophil
- Mechanism of Action
- Plant cell walls (fiber) that are RESISTANT to digestion by GI system –> forms gel-like substance that pushes on colonic wall and leads to mass peristaltic contractions
***Take with a lot of water***
Laxatives (Stool Softener)
e.g. Glycerin and Mineral Oil
- Mechanism of Action
- Two Theories:
a. Penetration of water/lipids into the stool
b. “coats” the stool with oil
Laxatives (Osmotic Agents)
e.g. Magnesium Hydroxide (Milk of Magnesia), Sorbitol, Lactulose, Polyethylene Glycol (PEG)
- Mechanism of Action
- Non-absorbable sugars and salts used to alter the osmotic pressure and pull water into the colon
Laxatives (Stimulant)
e.g. Anthraquinone derivatives (Aloe & Senna), Castor Oil, Diphenylmethane derivatives (Phenophthalein)
- Mechanism of Action
- Three Theories:
a. Stimulation of the ENS
b. Inducing a leaky mucosa
c. Inhibiting sodium uptake by the gut
Methylcellulose (Citrucel)
- Mechanism of Action
- Absorption
- Use
- Adverse Effects
MoA: BULK-FORMING; Fiber –> adds bulk and retains water
Absorption: Poor
Use: Constipation, Minimize Straining, Prior to Surgical and Endoscopic Procedures
AE: Gas/Bloating
Glycerin (Colace)
- Mechanism of Action
- Absorption
- Use
- Adverse Effects
MoA: SURFACTANT; Coats and Penetrates fecal material
Absorption: Poor
Use: Constipation, Minimize Straining, Prior to Surgical/Endoscopic Procedures
AE: Nutrient Malabsorption
Laculose (Enulose)
- Mechanism of Action
- Absorption
- Use
- Adverse Effects
MoA: OSMOTIC; Change osmotic pressure
Absorption: Poor
Use: Constipation, Minimize Straining, Prior to Surgical/Endoscopic Procedures
AE: Gas, Electrolyte Flux
Senna (Ex-Lax)
- Mechanism of Action
- Absorption
- Use
- Adverse Effects
MoA: STIMULANT; Stimulate ENS
Absorption: Poor
Use: Constipatio, Minimize Straining, Prior to Surgical/Endoscopic Procedures
AE: GI irritation
Tegaserod (Zelnorm)
- Mechanism of Action
- Absorption
- Use
- Adverse Effects
MoA: SEROTONIN AGONIST
***STIMULATES***
Serotonin (5-HT) stimulates pre-synaptic 5-HT4 receptors –> release of NT (e.g. Ach) in ENS –> INCREASED motility** and **DECREASED** **pain (via decreased firing of extrinsic sensory neurons to the CNS)
Absorption: 10%
Use: Chronic idiopathic constipation
AE: GI, CV ***Not available for general use - a LAST DITCH EFFORT TYPE OF DRUG***
Lubiprostone (Amitiza)
- Mechanism of Action
- Absorption
- Use
- Adverse Effects
MoA: CHLORIDE CHANNEL ACTIVATOR
Activates Chloride Ion Channel 2 (CIC-2) –> INCREASED** luminal concentration of **chloride in the gut –> accumulation of sodium and water –> motility
Absorption: Poor ***Accesses the apical/lumenal side, is NOT absorbed into the bloodsteram***
AE: Nausea/Vomiting, Diarrhea
Methylnaltrexone (Relistor)
- Mechanism of Action
- Absorption
- Use
- Adverse Effects
MoA: Mu-OPIOID RECEPTOR ANTAGONIST
Blocks PERIPHERAL Mu-opioid receptors (normally activated by opioids (e.g. morphine) and lead to DELAYED intestinal motility) –> prevents pain treatment-associated/post-surgical constipation
Absorption: ***Poor CNS penetration allows pain management and prevention of constipation
Use: Opioid-induced constipation during palliative care
AE: Abdominal pain, Flatulence, Nausea, Diarrhea
Alvimopan (Entereg)
- Mechanism of Action
- Absorption
- Use
- Adverse Effects
MoA: Mu-OPIOID RECEPTOR ANTAGONIST
Blocks PERIPHERAL Mu-opioid receptors (normally activated by opioids (e.g. morphine) and lead to DELAYED intestinal motility) –> prevents pain treatment-associated/post-surgical constipation
Absorption: ***Poor CNS penetration allows for pain management and prevention of constipation
Use: Postoperative Ileus in hospitalized patients with bowel resection
AE: GI similar to Methylnaltrexone
***Can cause Myocardial Infarction (so only short-term use, 7 days or less)
Antidiarrheal Agents (Opioids)
- Mechanism of Action
Frequently administered Orally
MoA: only have peripheral effects (do not cross BBB/do not enter CNS) to minimize abuse potential
Alter GI Smooth Muscle by:
a. Decreasing peristalsic contractions
b. Increasing segmental (mixing) contractions
c. Increasing internal anal sphincter tone
d. Decreasing perception of GI distension
Antidiarrheal Agents (Bismuth Subsalicylate)
- Mechanism of Action
Administered Orally
MoA: primarily mediated by salicylate inhibition of prostaglandin synthesis ***IN CONTRAST to what is occurring in the STOMACH
Also Bismuth compounds absorb bacterial toxins
Antidiarrheal Agents (Bile Salt Binding Resins)
- Mechanism of Action
MoA: reduce the osmotic pressure in the lumen of the large intestine by binding the unabsorbed bile salts
Antidiarrheal Agents (Octreotide)
- Mechanism of Action
Is a synthetic peptide (somatostatin analogue) so it has to be given IV or subcutaneously
MoA: activates somatostatin receptor, increasing fluid absorption and decreasing motility
Loperamide (Imodium)
- Mechanism of Action
- Use
- Adverse Effects
MoA: OPIOID AGONIST
Use: Diarrhea (IBS)
AE: Constipation (VERY SAFE)
Diphenoxylate (Lomotil)
- Mechanism of Action
- Use
- Adverse Effects
MoA: OPIOID AGONIST
Use: Diarrhea
AE: CNS Effects, Atropine Effects
***Given with Atropine to miniize abuse***
Bismuth subsalicylate (Pepto-Bismol)
- Mechanism of Action
- Use
- Adverse Effects
MoA: Inhibit PG Synthesis (Intenstinal), Absorb Toxins
Use: Non-specific diarrhea, Travelers diarrhea
AE: Salicylate Toxicity
Cholestyramine (Prevalite)
- Mechanism of Action
- Use
- Adverse Effects
MoA: Bind BILE ACIDS and SALTS
Use: Impaired bile salt absorption-mediated diarrhea
AE: Bloating, flatus, constipation; Fecal impaction; Impaired fat absorption/fat soluble vitamin absorption
Octreotide (Sandostatin)
- Mechanism of Action
- Use
- Adverse Effects
MoA: Somatostatin receptor agonist
Use: Secretory diarrhea
AE: Impaired pancreatic secretion, Decreased GI motility (nausea, pain), Decreased gallbladder contraction, Glucose hemostasis
What are the key receptors that regulate an emetic response in the Vestibular system?
Histamine (H1) and Muscarinic (M1)
What are the receptors that are involved in an emetic response? (7 of them)
Histamine (H1)
Muscarinic (M1)
Dopamine (D2)
Neurokinin (NK1)
Serotonin (5-HT)
Chemoreceptors
Mechanoreceptors
Ondansetron (Zofran)
- Mechanism of Action
- Adverse Effects
MoA: 5-HT3 (Serotonin) Antagonist
AE: Headache, Dizziness, Constipation, Prolonged QT Interval
Scopolamine (Transderm Scop)
- Mechanism of Action
- Adverse Effects
- Use
MoA: M1 Antagonist (Vestibular System)
AE: Antimuscarinic Effects
Use: Motion Sickness
***Patch behind the ear***
Metocloramide (Octamide)
MoA: D2 Antagonist
AE: Extrapyramidal (Parkinsonian Symptoms)
Dimenhydrinate (Dramamine)
- Mechanism of Action
- Adverse Effects
- Use
MoA: H1 Antagonist (Vestibular System)
AE: Drowsiness
Use: Motion Sickness
Aprepitant (Emend)
- Mechanism of Action
- Adverse Effects
MoA: NK1 Antagonist
AE: Fatigue, Dizziness, Diarrhea, CYP3A4 Interactions (leads to drug-drug interactions)
Prochlorperazine (Compro)
- Mechanism of Action
- Adverse Effects
MoA: M1D2H1 Antagonist (***Last Resort***(severe conditions)–> knocks out all receptors)
AE: Extrapyramidal, Drowsiness, Anticholinergic
Lorazepam (Ativan)
- Mechanism of Action
- Adverse Effects
- Uses
MoA: GABA Agonist
AE: Drowsiness
Uses: Indirect Antiemetic, Anxiety, Chemotherapy
Nabilone (Cesamet)
- Mechanism of Action
- Adverse Effects
MoA: Cannabinoid Agonist
Uses: Indirect Antiemetic
AE: Dysphoria, Sedation, Increased Appetite
Dexamethasone
- Mechanism of Action
- Adverse Effects
- Uses
MoA: Glucocorticoid Agonist (LAST RESORT (Extreme situations))
AE: Weight Gain, Water Retention, Other corticosteroid effects
Uses: Indirect Antiemetic, Chemotherapy, Post-operative
***Increases the effectiveness of 5-HT antagonists***
How do aminosolicylates work?
Topical
***DO NOT want systemic absorption - will NOT work***
Irritable Bowel Syndrome (IBS)
- Definition
- Cause
- Treatments
- Idiopathic chronic relapsing disorder charactereized by abdominal discomfort (pain, bloating, distension, or cramps) in association with alterations in bowel habits (diarrhea, constipation, or both)
Cause: Uncertain
Tx: Loperamide (reduces diarrhea), Osmotic laxatives (relieves constipation), as well as tricyclic antidepressants and antispasmodics/antimuscarinics (relieves pain)
Tegaserod (Zelnorm) vs. Alosetron (Lotrenex)
- Mechanism of Action
- Use
- Adverse Effects
Tegaserod (Zelnorm)
MoA: 5-HT4 partial agonist
Use: IBS-constipation predominant
AE: GI (pain, dyspepsia, flatulence, nausea/vomiting, diarrhea), CV (0.01%, MI and Stroke) ***Not available for general use - EMERGENCY only***
Alosetron (Lotrenex)
MoA: 5-HT3 ANTagonist
Use: IBS-diarrhea predominant (works in WOMEN only)
AE: Constipation (29%), ***Ischemic colitis (fatal)***
Inflammatory Bowel Disease (IBD)
- Key thing to think about
- Two specific diseases
- INFLAMMATION
- Crohn’s Disease and Ulcerative Colitis
Crohn’s Disease vs. Ulcerative Colitis
Crohn’s Disease: an idiopathic inflammatory disorder that affects ANY PART of the GI tract
Ulcerative Colitis: a chronic inflammatory disease that causes ulcerations of the COLONIC/DISTAL mucosa of the GI tract
Aminosalicylates (ASA)
- Mechanism of Action
MoA:
- Inhibition of COX production of prostaglandins
- Interfere with inflammatory cytokine production (i.e. IL-1)
- Inhibit NF-KB signaling
How do 5-aminosalicylic acid (5-ASA) compounds work?
They are administered TOPICALLY to the GI site; they will not work if they are absorbed into the bloodstream
-Requires use of Proprietary Release Formulas (Jejunum, Ileum), Chemical Binding (Proximal Colon), and High Concentration Enemas (Distal Colon and Rectum)
Which two 5-aminosalicylic acid (5-ASA) drugs are used to treat Inflammatory Bowel Disease (IBD)?
Sulfalazine
Mesalamine
Which two Glucocorticoids treat IBD, and what is their general mechanism of action?
Prednisone
Hydrocortisone
MoA: Suppress inflammatory cytokines, signaling, etc.
How do antimetabolites work to treat IBD, and what is an example of one?
MoA: Suppress cell proliferation of immune cells
Example: Methotrexate
Anti-TNFa Therapy
- Mechanism of Action
- Example
MoA: TNFa monoclonal antibody (a protein) is administered IV or subQ –> binds and sequesters TNFa –> Inhibit TNFa-mediated immune response
Example: Infliximab
Sulfsalazine (Azulfidine)
- Type of Agent
- Use
- Adverse Effects
Agent: Amicosalicylate (ASA)
Use: 1st line agent for mild to moderate ulcerative colitis
AE: Nausea, GI upset, headache, arthralgia, myalgia, bone marrow suppression, malaise (40% of patients cannot tolerate)
Mesalamine (Pentasa)
- Type of Agent
- Use
- Adverse Effects
Agent: Aminosalicylate (ASA)
Use: 1st line agent for mild to moderate ulcerative colitis
AE: Headache, Dizzines, Abdominal Pain
Prednisone (Predone)
- Type of Agent
- Use
- Adverse Effects
Agent: Glucocorticoid (STEROID)
Use: Moderate to Severe *ACTIVE* IBD
AE: Glucocorticoid adverse effects
Azathioprine (Azasan)
- Type of Agent
- Use
- Adverse Effects
Agent: Antimetabolite
Use: Maintenance of REMISSION of IBD (onset 17 weeks)
AE: Nausea, vomiting, bone marrow suppression
Methotrexate (Rheumatrex)
- Type of Agent
- Use
- Adverse Effects
Agent: Antimetabolite
Use: Maintenance of REMISSION of Crohn’s (onset 8-12 weeks)
AE: Low dose side effects uncommon, but include bone marrow depression and megaloblastic anemia
Infliximab (Remicade)
- Type of Agent
- Use
- Adverse Effects
Agents: Anti TNFa antibody
Use: Will look at 5-ASA compounds and Steroids BEFORE LOOKING AT THIS
Consider this when moving into the Moderate to Severe IBD
AE: Infection